Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
AUTOR(ES)
Herchenhorn, Daniel, Dienstmann, Rodrigo, Peixoto, Fabio A., Campos, Franz S. de, Santos, Valdelice O., Moreira, Denise M., Cardoso, Hedilene, Small, Isabele A., Ferreira, Carlos G.
FONTE
International braz j urol
DATA DE PUBLICAÇÃO
2007-12
RESUMO
Documentos Relacionados
- Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
- A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102
- Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
- Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
- Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma